Lemon Tree Hotels by ICICI SecuritiesAnalysis dated 18 November 2024Sector: Hotel, Resort & RestaurantsPrice on Analysis date: Rs. 122Target Rs. 164(34% Upside potential)Target Period: 12 Months Lemon Tree Hotels Stock Research Report Strong bounce back; demand outlook remains robust….. Lemon Tree Hotels (LEMONTRE) reported Q2FY25 consol. revenue of INR 2.8bn (up 25% YoY) in-line with […]
Read more..Glenmark Pharmaceuticals by ICICI SecuritiesAnalysis dated 18 November 2024Sector: Pharmaceuticals & DrugsPrice on Analysis date: Rs. 1486Target Rs. 1345(-9% Downside potential)Target Period: 12 Months Glenmark Pharmaceuticals Stock Research Report Overheads dent performance, bracing for a recovery ahead….. Glenmark Pharmaceuticals’ (Glenmark) Q2FY25 result was dragged by a muted showing in US (-2.5% YoY) and sharp jump […]
Read more..Ashoka Buildcon by ICICI SecuritiesAnalysis dated 14 November 2024Sector: Construction – InfrastructurePrice on Analysis date: Rs. 233Target Rs. 311(33% Upside potential)Target Period: 12 Months Ashoka Buildcon Stock Research Report CDPQ deal remains the highlight for Q2FY25; FY26 outlook remains strong….. Ashoka Buildcon’s Q2FY25 earnings saw YoY decline in growth. However, the outlook remains strong for […]
Read more..Borosil by ICICI SecuritiesAnalysis dated 14 November 2024Sector: Glass & Glass ProductsPrice on Analysis date: Rs. 438Target Rs. 468(7% Upside potential)Target Period: 12 Months Borosil Stock Research Report Capacity addition in core glassware segment drives growth….. Takeaways: (1) Borosil reported strong industry leading revenue growth (+16.6% YoY) amid challenging demand environment. Capacity ramp-up in core […]
Read more..Cello World by ICICI SecuritiesAnalysis dated 14 November 2024Sector: Household & Personal ProductsPrice on Analysis date: Rs. 816Target Rs. 940(15% Upside potential)Target Period: 12 Months Cello World Stock Research Report Scathed due to macros; execution on track. We remain optimistic….. While Cello’s Q2FY25 was below our and consensus expectations, we highlight positives (1) Glassware unit […]
Read more..Sun TV Network by ICICI SecuritiesAnalysis dated 14 November 2024Sector: TV Broadcasting & Software ProductionPrice on Analysis date: Rs. 725Target Rs. 1111(53% Upside potential)Target Period: 12 Months Sun TV Network Stock Research Report Some green shoots, but still a long way to go….. In Q2FY25, Sun TV’s ad revenue grew 2.1% YoY, which we believe […]
Read more..Kalyan Jewellers India by ICICI SecuritiesAnalysis dated 14 November 2024Sector: Diamond & JewelleryPrice on Analysis date: Rs. 670Target Rs. 740(10% Upside potential)Target Period: 12 Months Kalyan Jewellers India Stock Research Report Revenue outperformance with sustained profitability….. Q2FY25 continues to enhance confidence in Kalyan’s business model (FOCO) as it continues to outperform competition by gaining market […]
Read more..Cera Sanitaryware by ICICI SecuritiesAnalysis dated 13 November 2024Sector: Ceramics/Marble/Granite/SanitarywarePrice on Analysis date: Rs. 6765Target Rs. 8416(24% Upside potential)Target Period: 12 Months Cera Sanitaryware Stock Research Report Muted quarter, H2FY25 to be better; upgrade to BUY on reasonable valuations….. Cera Sanitaryware (CRS) reported Q2FY25 consol. revenue growth of 6.4% YoY with faucetware growing ~20% YoY […]
Read more..Natco Pharma by ICICI SecuritiesAnalysis dated 13 November 2024Sector: Pharmaceuticals & DrugsPrice on Analysis date: Rs. 1367Target Rs. 1430(5% Upside potential)Target Period: 12 Months Natco Pharma Stock Research Report Strong quarter, pipeline build-up underway….. Natco’s Q2FY25 result was strong driven by gRevlimid. Cashflow generated from gRevlimid windfall is being used to develop NCEs, oligonucleotides and […]
Read more..Alkem Laboratories by ICICI SecuritiesAnalysis dated 13 November 2024Sector: Pharmaceuticals & DrugsPrice on Analysis date: Rs. 5571Target Rs. 6155(10% Upside potential)Target Period: 12 Months Alkem Laboratories Stock Research Report Growth to accelerate ahead, FY25 margin guidance raised….. Alkem Laboratories (Alkem) Q2FY25 revenue growth was dragged by a sharp fall of 22.1% YoY in US while […]
Read more..
November 26, 2024
analysis123 analysis123
